loading
Precedente Chiudi:
$12.85
Aprire:
$12.74
Volume 24 ore:
76,364
Relative Volume:
0.06
Capitalizzazione di mercato:
$759.33M
Reddito:
-
Utile/perdita netta:
$-130.41M
Rapporto P/E:
-5.4866
EPS:
-2.24
Flusso di cassa netto:
$-67.76M
1 W Prestazione:
+0.89%
1M Prestazione:
+60.59%
6M Prestazione:
+150.10%
1 anno Prestazione:
+39.66%
Intervallo 1D:
Value
$12.25
$12.99
Intervallo di 1 settimana:
Value
$11.98
$13.22
Portata 52W:
Value
$3.5001
$13.22

Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile

Name
Nome
Monte Rosa Therapeutics Inc
Name
Telefono
617-949-2643
Name
Indirizzo
321 HARRISON AVENUE, BOSTON
Name
Dipendente
142
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
GLUE's Discussions on Twitter

Confronta GLUE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GLUE
Monte Rosa Therapeutics Inc
12.29 793.61M 0 -130.41M -67.76M -2.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.65 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
638.50 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
443.80 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
824.69 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.38 40.44B 447.02M -1.18B -868.57M -6.1812

Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-19 Downgrade Wells Fargo Overweight → Equal Weight
2024-02-15 Iniziato Wedbush Outperform
2023-01-03 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-10-13 Iniziato UBS Buy
2022-08-15 Iniziato Jefferies Buy
2022-04-28 Iniziato Credit Suisse Neutral
2022-02-10 Iniziato Wells Fargo Equal Weight
2021-10-14 Iniziato SVB Leerink Mkt Perform
Mostra tutto

Monte Rosa Therapeutics Inc Borsa (GLUE) Ultime notizie

pulisher
07:14 AM

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

07:14 AM
pulisher
04:31 AM

What to do if you’re stuck in Monte Rosa Therapeutics Inc.Dividend Hike & Low Risk Investment Opportunities - newser.com

04:31 AM
pulisher
03:03 AM

Is it time to cut losses on Monte Rosa Therapeutics Inc.Market Volume Report & Stock Timing and Entry Methods - newser.com

03:03 AM
pulisher
02:37 AM

Is Monte Rosa Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Decliners & Accurate Technical Buy Alerts - newser.com

02:37 AM
pulisher
01:47 AM

Why Monte Rosa Therapeutics Inc. stock could benefit from AI revolutionWeekly Stock Report & High Return Trade Guides - newser.com

01:47 AM
pulisher
01:22 AM

Chart based exit strategy for Monte Rosa Therapeutics Inc.2025 Top Gainers & Community Verified Trade Signals - newser.com

01:22 AM
pulisher
Nov 02, 2025

Forecasting Monte Rosa Therapeutics Inc. price range with options dataMarket Movers & Safe Entry Trade Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Cwm LLC Raises Holdings in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Monte Rosa Therapeutics, Inc. (GLUE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 01, 2025
pulisher
Nov 01, 2025

Monte Rosa Therapeutics, Inc. (GLUE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 01, 2025
pulisher
Nov 01, 2025

Monte Rosa Therapeutics (NASDAQ:GLUE) Given Sell (D+) Rating at Weiss Ratings - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

Monte Rosa Therapeutics Hits New 52-Week High of $13.10 - Markets Mojo

Oct 31, 2025
pulisher
Oct 31, 2025

Monte Rosa Therapeutics (GLUE) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Custom watchlist performance reports with Monte Rosa Therapeutics Inc.Bull Run & Technical Entry and Exit Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Visual trend scoring systems applied to Monte Rosa Therapeutics Inc.Weekly Market Summary & Expert-Curated Trade Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Monte Rosa Therapeutics Inc. stock is popular among millennialsJuly 2025 Outlook & Technical Pattern Alert System - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Monte Rosa Therapeutics Advances MRT-2359 in MYC-Driven Cancer Study - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Monte Rosa Therapeutics Hits New 52-Week High of $12.97 - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Monte Rosa Therapeutics Advances with MRT-8102: A Promising Phase 1 Study - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

What analysts say about Monte Rosa Therapeutics Inc stockDividend Reinvestment Plans & Small Investment Growth Tips - earlytimes.in

Oct 30, 2025
pulisher
Oct 30, 2025

How Regulatory Changes Could Impact ICDS Limiteds BusinessRelative Strength Index (RSI) & Learn to Trade Without Fear of Loss - earlytimes.in

Oct 30, 2025
pulisher
Oct 30, 2025

Working capital per share of Monte Rosa Therapeutics, Inc. – NASDAQ:GLUE - TradingView

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 01:39:11 - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance

Oct 29, 2025
pulisher
Oct 28, 2025

Monte Rosa Therapeutics (NASDAQ:GLUE) Reaches New 1-Year HighStill a Buy? - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Why Monte Rosa Therapeutics Inc. stock is trending among retail tradersJuly 2025 EndofMonth & Weekly High Return Stock Forecasts - fcp.pa.gov.br

Oct 28, 2025

Monte Rosa Therapeutics Inc Azioni (GLUE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.52
price up icon 0.03%
$93.16
price down icon 0.32%
$28.84
price up icon 0.79%
$104.30
price up icon 0.20%
biotechnology ONC
$313.33
price up icon 0.97%
$184.11
price down icon 2.65%
Capitalizzazione:     |  Volume (24 ore):